Eliane Miyaji
0000-0003-1689-5366
51 papers found
Refreshing results…
Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice
Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations
Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A)
Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection
The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease
Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains
Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice
Characterization of Protective Mucosal and Systemic Immune Responses Elicited by Pneumococcal Surface Protein PspA and PspC Nasal Vaccines against a Respiratory Pneumococcal Challenge in Mice
Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades
Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production
Fusion Proteins Containing Family 1 and Family 2 PspA Fragments Elicit Protection against Streptococcus pneumoniae That Correlates with Antibody-Mediated Enhancement of Complement Deposition
Optimizing Expression of Streptococcus pneumoniae Surface Protein a, PspA: Serocross-Reactivity within Families of Antisera Induced Against Clades 1 and 3
Mycobacterial codon optimization of the gene encoding the Sm14 antigen ofSchistosoma mansoniin recombinantMycobacterium bovisBacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice
Intranasal Immunization with the Cholera Toxin B Subunit-Pneumococcal Surface Antigen A Fusion Protein Induces Protection against Colonization with Streptococcus pneumoniae and Has Negligible Impact on the Nasopharyngeal and Oral Microbiota of Mice
Genetic Diversity of PspA Types among Nasopharyngeal Isolates Collected during an Ongoing Surveillance Study of Children in Brazil
Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A
DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein
DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge withStreptococcus pneumoniae
Intradermal Immunization of Mice with Cholera Toxin B-Pneumococcal Surface Protein A Fusion Protein Is Protective against Intraperitoneal Challenge with Streptococcus pneumoniae
Missing publications? Search for publications with a matching author name.